Phase Genomics Receives $1.5MM NIH Grant to Develop Fast and Affordable Commercial Antimicrobial Resistance Tracking Kit
January 08, 2020 09:30 ET | Phase Genomics
SEATTLE, Washington, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Phase Genomics, Inc., the biotech leader providing proximity-ligation next-generation sequencing (NGS) solutions for metagenome assembly, today...
Phase Genomics’ Platform Links Viruses and Antibiotic Resistance Genes to the Microbiome in Study of a Highly Complex Microbial Community
August 06, 2019 09:15 ET | Phase Genomics
SEATTLE, Washington, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Phase Genomics, Inc., the leading provider of proximity ligation next generation sequencing (NGS) solutions for genomics and metagenomics, in...
Phase Genomics Accelerates Microbiome Discovery and Antibiotic Resistance tracking with New ProxiMeta™ 8-Pack Including Bundled Analysis
June 20, 2019 09:05 ET | Phase Genomics
SEATTLE, Washington, June 20, 2019 (GLOBE NEWSWIRE) -- Phase Genomics, Inc., the biotech leader providing proximity ligation solutions for genome and metagenome assembly, announces its new...
Leading-Edge Microbiome Discovery Platform Receives New Funding
February 25, 2019 09:17 ET | Phase Genomics
SEATTLE, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Phase Genomics, the leader in proximity ligation-based genomic solutions, announced today a year-long grant awarded by the Bill & Melinda Gates...
New Genomic Technology Advances Fight Against Global Health Threat of Antibiotic Resistance
December 06, 2018 09:14 ET | Phase Genomics
SEATTLE, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Phase Genomics, the leader in proximity-ligation genome assembly technology released an antimicrobial resistance (AMR) study led by researchers from the...
Phase Genomics Announces 6 New Asia Pacific Distribution Partnerships
October 21, 2018 21:15 ET | Phase Genomics
Seattle, Oct. 21, 2018 (GLOBE NEWSWIRE) -- Phase Genomics, the leader in Hi-C proximity-ligation based genomic solutions, announced today agreements with six life science technology distributors...